Lung Cancers Today

Kaitlyn KoskoSmall Cell Lung Cancer | April 19, 2024
The timing of chemotherapy given to patients with SCLC does not have a statistically significant impact on OS.
Read More
Kaitlyn KoskoSmall Cell Lung Cancer | April 18, 2024
The timing of chemotherapy given to patients with SCLC does not have a statistically significant effect on OS.
Kaitlyn KoskoLung Cancer | April 18, 2024
Lung cancer screening discussions are not happening as often as they could be among health care providers.
Kaitlyn KoskoLung Cancer | April 18, 2024
The postoperative comfort scale has good reliability and validity, and can be used to assess patients with lung cancer.
Leah LawrenceLung Cancer | April 17, 2024
Just under a quarter of a million new cases of lung cancer were diagnosed in 2023, with 10-20% in non-smokers.
Kaitlyn KoskoNon-Small Cell Lung Cancer | April 17, 2024
Preoperative ctDNA has prognostic value for determining long-term prognosis for NSCLC.
Kaitlyn KoskoNon-Small Cell Lung Cancer | April 17, 2024
Clinical trial investigators should use a mindful approach when planning to assess HRQOL in NSCLC.
Kaitlyn KoskoNon-Small Cell Lung Cancer | April 17, 2024
It is reasonable to upgrade ECE of tumor in lymph nodes from R0 to incomplete resection.
Kaitlyn KoskoNon-Small Cell Lung Cancer | April 17, 2024
Worse clinical outcomes and higher risk for brain metastasis are more likely to happen in patients with metastatic NSCLC.
Kaitlyn KoskoMesothelioma | April 17, 2024
Occupational asbestos exposure leads to shorter survival in patients with malignant mesothelioma.
Kaitlyn KoskoMesothelioma | April 17, 2024
Guideline-concordant therapy remains underused in most mesothelioma patients.
Eileen Koutnik-FotopoulosLung Cancer | April 16, 2024
Researchers looked at unique features in epidemiology, risk factors, and biology of lung cancer in women.
Kaitlyn KoskoLung Cancer | March 28, 2024
Opportunistic screening for lung cancer helped lower the risk of death related to the disease in China.
Kaitlyn KoskoLung Cancer | March 28, 2024
Low-dose computed tomography can reduce the number of deaths from lung cancer in Brazil.
Kaitlyn KoskoNon-Small Cell Lung Cancer | March 28, 2024
The use of tobacco negatively affects survival outcomes in patients with advanced NSCLC.
Kaitlyn KoskoNon-Small Cell Lung Cancer | March 28, 2024
Patients with EGFR-positive metastatic NSCLC whose disease progressed following first-line treatment have worse outcomes.
Kaitlyn KoskoNon-Small Cell Lung Cancer | March 28, 2024
Patient selection for perioperative immunotherapies may be determined by specific intratumoral immune cells.
Mary GreccoNon-Small Cell Lung Cancer | March 28, 2024
A study explored the potential benefits of combining first-generation EGFR-TKI with chemotherapy as neoadjuvant treatment.
Mary GreccoNon-Small Cell Lung Cancer | March 26, 2024
The VISION study that evaluated pre/post-tepotinib treatment in advanced/metastatic METex14 skipping NSCLC.
Mary GreccoSmall Cell Lung Cancer | March 26, 2024
The DeLLphi-301 study that evaluated patients with advanced SCLC.
Advertisement
Advertisement
Latest News

April 19, 2024